切换至 "中华医学电子期刊资源库"

中华胃食管反流病电子杂志 ›› 2022, Vol. 09 ›› Issue (01) : 6 -11. doi: 10.3877/cma.j.issn.2095-8765.2022.01.002

论著

胃食管反流病合并心房颤动患者的临床特点及危险因素
李金贤1, 程新春2,()   
  1. 1. 830000 乌鲁木齐,新疆维吾尔自治区人民医院康复医学科
    2. 830000 乌鲁木齐,新疆维吾尔自治区人民医院老年医学中心
  • 收稿日期:2021-10-23 出版日期:2022-02-15
  • 通信作者: 程新春

Clinical characteristics and risk factors of gastroesophageal reflux disease complicated with atrial fibrillation

Jinxian Li1, Xinchun Cheng2,()   

  1. 1. Department of Rehabilitation Medicine, Xinjiang Uygur Autonomous Region People's Hospital, Urumqi 830000, China
    2. Department of Geriatrics Center, Xinjiang Uygur Autonomous Region People's Hospital, Urumqi 830000, China
  • Received:2021-10-23 Published:2022-02-15
  • Corresponding author: Xinchun Cheng
引用本文:

李金贤, 程新春. 胃食管反流病合并心房颤动患者的临床特点及危险因素[J/OL]. 中华胃食管反流病电子杂志, 2022, 09(01): 6-11.

Jinxian Li, Xinchun Cheng. Clinical characteristics and risk factors of gastroesophageal reflux disease complicated with atrial fibrillation[J/OL]. Chinese Journal of Gastroesophageal Reflux Disease(Electronic Edition), 2022, 09(01): 6-11.

目的

分析胃食管反流病(GERD)患者发生心房颤动(AF)的可能危险因素。

方法

回顾性纳入2008年1月到2021年1月在新疆维吾尔自治区人民医院住院的胃食管反流病患者7417例。为研究GERD患者中AF发生的危险因素,采用单因素logistic 回归逐步法筛选有意义自变量,后通过多因素logistic 回归进行进一步分析。

结果

本研究纳入研究对象平均年龄59岁,其中男性占54.8%,14.2%患者合并2型糖尿病,32.5%合并高血压,12.1%合并冠状动脉粥样硬化心脏病。入组的患者中共有合并 AF患者54例。通过logistic 回归进行单因素变量筛选。控制已知的AF的混杂因素后(年龄、性别、吸烟、饮酒、糖尿病病史、高血压病史、冠心病病史、低密度脂蛋白胆固醇、总胆固醇)后进行多因素logistic 回归,结果提示年龄(OR=1.06,95%CI:1.04~1.09)、血清谷草转氨酶(OR=1.004,95%CI:1.001~1.005)和γ-谷氨酰基转移酶(OR=1.001,95%CI:1.000~1.003)是 GERD患者发生AF的危险因素。

结论

本研究提示高龄、谷草转氨酶 和γ-谷氨酰基转移酶水平可能是GERD 患者发生 AF 的危险因素。

Objective

To analyze the possible risk factors of atrial fibrillation (AF) in patients with Gastroesophageal reflux disease (GRED).

Methods

A total of 7417 patients with GERD were enrolled according to strict inclusion and exclusion criteria. Logistic regression model was used for statistical analysis.

Results

The mean age of our subjects was 59 years, 54.8% were male, 14.2% had diabetes mellitus, 32.5% had hypertension, and 12.1% had coronary artery disease (CAD). 54 patients were diagnosed with AF. After controlling for traditional risk factors of AF (age, sex, smoking, alcohol consumption, history of diabetes, history of hypertension, history of coronary heart disease, low density lipoprotein cholesterol, and total cholesterol), multivariate logistic regression indicated that age (OR: 1.06, 95%CI: 1.04-1.09), glutamic oxalacetic transaminase (AST) (OR: 1.004, 95%CI: 1.001-1.005) and γ-glutamyl transferase (γ-GGT) (OR: 1.001, 95%CI: 1.000-1.003) were risk factors for AF in patients with GERD.

Conclusion

This study suggestsed that advanced age, AST and γ-GGT levels may be risk factors for AF in GERD patients.

表1 7417例患者临床基本资料
年龄[岁,MQ1Q3)] 59.0(51.0,67.0)
性别[例(%)]
男性 4067(54.8)
女性 3350(45.2)
民族[例(%)]
汉族 3796(51.2)
维吾尔族和哈萨克族 2980(40.2)
其他 641(8.64)
BMI[kg/m2MQ1Q3)] 25.3(23.5,27.3)
收缩压[mmHg,MQ1Q3)] 124(114,135)
舒张压[mmHg,MQ1Q3)] 77.0(70.0,83.0)
脉搏[次/min,MQ1Q3)] 78.0(76.0,82.0)
吸烟[例(%)]
5053(68.1)
2364(31.9)
饮酒[例(%)]
5257(70.9)
2160(29.1)
糖尿病病史[例(%)]
6365(85.8)
1052(14.2)
高血压病史[例(%)]
5004(67.5)
2413(32.5)
冠心病病史[例(%)]
6519(87.9)
898(12.1)
心房颤动[例(%)]
7363(99.3)
54(0.73)
脑梗病史[例(%)]
7246(97.7)
171(2.31)
慢性支气管炎[例(%)]
6963(93.9)
454(6.12)
阻塞性睡眠呼吸暂停综合征[例(%)]
7128(96.1)
289(3.90)
谷丙转氨酶[U/L,MQ1Q3)] 20.0(14.0,30.0)
谷草转氨酶[U/L,MQ1Q3)] 19.0(16.0,24.0)
血肌酐[μmol/L,MQ1Q3)] 65.6(56.1,75.9)
血尿素氮[μmol/L,MQ1Q3)] 0.18(0.08,5.05)
甘油三脂[mmol/L,MQ1Q3)] 1.38(0.99,1.96)
低密度脂蛋白胆固醇[mmol/L,MQ1Q3)] 2.66(2.12,3.22)
总胆固醇[mmol/L,MQ1Q3)] 4.43(3.82,5.10)
高密度脂蛋白胆固醇[mmol/L,MQ1Q3)] 1.04(0.88,1.24)
血钾[mmol/L,MQ1Q3)] 3.93(3.70,4.15)
超敏C反应蛋白[mg/dl,MQ1Q3)] 1.38(0.72,2.82)
肌酸激酶U/L,MQ1Q3)] 75.0(55.9,101)
血尿酸[μmol/L,MQ1Q3)] 299(243,364)
白细胞计数[109/L,MQ1Q3)] 6.13(5.07,7.35)
中性粒细胞计数[109/L,MQ1Q3)] 3.50(2.75,4.42)
淋巴细胞计数[109/L,MQ1Q3)] 1.92(1.54,2.36)
单核细胞计数[109/L,MQ1Q3)] 0.40(0.30,0.51)
血红蛋白[g/L,MQ1Q3)] 142(130,154)
血小板计数[109/L,MQ1Q3)] 232(194,275)
嗜酸性粒细胞计数[109/L,MQ1Q3)] 0.11(0.05,0.19)
红细胞计数[109/L,MQ1Q3)] 4.69(4.34,5.05)
红细胞压积[MQ1Q3)] 0.43(0.40,0.46)
γ-谷氨酰基转移酶[U/L,MQ1Q3)] 23.0(16.0,39.0)
血钠[mmol/L,MQ1Q3)] 141(139,143)
表2 单因素 logistic 回归筛选胃食管反流病患者发生心房颤动的危险因素
变量 OR 95%CI P
年龄 1.080 1.060~1.110 <0.001
性别
男性 Ref. Ref.
女性 0.710 0.400~1.240 0.232
民族
汉族 Ref. Ref.
维吾尔族和哈萨克族 0.960 0.530~1.690 0.880
其他 1.090 0.360~2.600 0.869
BMI 1.000 0.930~1.070 0.985
收缩压 1.000 0.990~1.020 0.608
舒张压 1.000 0.980~1.030 0.816
脉搏 0.970 0.930~1.010 0.120
吸烟
Ref. Ref.
0.830 0.440~1.470 0.528
饮酒
Ref. Ref.
0.630 0.310~1.180 0.153
糖尿病病史
Ref. Ref.
2.150 1.120~3.880 0.023
高血压病史
Ref. Ref.
3.280 1.900~5.780 <0.001
冠心病病史
Ref. Ref.
4.020 2.240~6.990 <0.001
阻塞性睡眠呼吸暂停综合征
Ref. Ref.
0.530 0.020~2.380 0.488
慢性支气管炎
Ref. Ref.
3.580 1.680~6.900 0.002
谷丙转氨酶 1.001 0.999~1.003 0.089
谷草转氨酶 1.004 1.001~1.007 0.001
血肌酐 1.003 1.000~1.005 0.028
血尿素氮 1.060 0.990~1.150 0.108
甘油三脂 0.720 0.500~1.030 0.071
低密度脂蛋白胆固醇 0.600 0.420~0.840 0.003
总胆固醇 0.620 0.470~0.830 0.001
高密度脂蛋白胆固醇 0.360 0.130~1.010 0.052
血钾 1.880 0.930~3.780 0.077
超敏C反应蛋白 1.000 0.980~1.020 0.977
肌酸激酶 1.000 0.990~1.000 0.209
血尿酸 1.000 1.000~1.000 0.148
白细胞计数 0.960 0.850~1.090 0.570
中性粒细胞计数 1.030 0.890~1.180 0.722
淋巴细胞计数 0.640 0.410~1.000 0.048
单核细胞计数 1.870 0.450~7.720 0.390
血红蛋白 0.980 0.970~1.000 0.006
血小板 1.000 0.990~1.000 0.050
嗜酸性粒细胞计数 0.410 0.050-3.460 0.414
红细胞计数 0.820 0.580~1.170 0.279
红细胞压积 1.020 0.990~1.040 0.141
γ-谷氨酰基转移酶 1.000 1.000~1.000 0.048
血钠 0.970 0.880~1.070 0.552
表3 多因素 logistic 回归筛选胃食管反流病患者发生心房颤动的危险因素
图1 年龄、谷草转氨酶和γ-谷氨酰基转移酶的多因素 logistic 回归结果
1
Clarrett DM, Hachem C. Gastroesophageal reflux disease (GERD)[J]. Mo Med 2018, 115(3):214-218.
2
El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review[J]. Gut, 2014, 63(6):871-880.
3
Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon consensus[J]. Gut, 2018, 67(7):1351-1362.
4
中华医学会消化病学分会. 2020年中国胃食管反流病专家共识[J].中华消化杂志, 2020, 40(10): 649-663.
5
Katzka DA, Kahrilas PJ. Advances in the diagnosis and management of gastroesophageal reflux disease[J]. BMJ, 2020, 371: m3786.
6
Yamasaki T, Sakiani S, Maradey-Romero C, et al. Barrett's esophagus patients are becoming younger: analysis of a large United States dataset[J]. Esophagus, 2020, 17(2):190-196.
7
Alimi Y, Azagury DE. gastroesophageal reflux disease and the patient with obesity[J]. Gastroenterol Clin North Am, 2021, 50(4):859-870.
8
Kurin M, Shibli F, Kitayama Y, et al. Sorting out the relationship between gastroesophageal reflux disease and sleep[J]. Curr Gastroenterol Rep 2021, 23(9):15.
9
Maret-Ouda J, Markar SR, Lagergren J. gastroesophageal reflux disease: a review[J]. JAMA, 2020, 324(24):2536-2547.
10
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告 2020 概要[J].中国循环杂志, 2021, 36(6): 521-545.
11
Lip GY, Fauchier L, Freedman SB, et al. Atrial fibrillation[J]. Nat Rev Dis Primers, 2016, 2:16016.
12
Dai H, Zhang Q, Much AA, et al. Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990-2017: results from the Global Burden of Disease Study 2017[J]. Eur Heart J Qual Care Clin Outcomes, 2021, 7(6):574-582.
13
Kamel H, Okin PM, Elkind MS, et al. Atrial fibrillation and mechanisms of stroke: time for a new model[J]. Stroke, 2016, 47(3):895-900.
14
Odashiro K, Yasuda S, Yokoyama T, et al. Prevalence of gastroesophageal reflux disorder in arrhythmic patients and adjunctive effects of proton pump inhibitors on comorbid atrial fibrillation[J]. Int J Basic Clin Pharmacol, 2015, 4:644-650.
15
Huang TC, Lo LW, Yamada S, et al. Gastroesophageal reflux disease and atrial fibrillation: Insight from autonomic cardiogastric neural interaction[J]. J Cardiovasc Electrophysiol, 2019, 30(11):2262-2270.
16
Mohamed A, Ochoa Crespo D, Kaur G, et al. Gastroesophageal reflux and its association with atrial fibrillation: a traditional review[J]. Cureus, 2020, 12(9):e10387.
17
Chatterjee NA, Giulianini F, Geelhoed B, et al. Genetic obesity and the risk of atrial fibrillation: causal estimates from Mendelian randomization[J]. Circulation, 2017, 135(8):741-754.
18
Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis[J]. Lancet Respir Med, 2019, 7(8):687-698.
19
Sun X, Chen L, Zheng L. A mendelian randomization study to assess the genetic liability of gastroesophageal reflux disease for cardiovascular diseases and risk factors[J]. Hum Mol Genet, 2022, ddac162.
20
Linz D, Hohl M, Vollmar J, et al. Atrial fibrillation and gastroesophageal reflux disease: the cardiogastric interaction[J]. Europace, 2017, 19(1):16-20.
21
Lin K, Chen X, Zhang L, et al. Proton pump inhibitors as also inhibitors of atrial fibrillation[J]. Eur J Pharmacol, 2013, 718(1-3):435-440.
22
Linz D, Hohl M, Vollmar J, et al. Atrial fibrillation and gastroesophageal reflux disease: the cardiogastric interaction[J]. Europace, 2017, 19(1):16-20.
23
Maruyama T, Fukata M, Akashi K. Association of atrial fibrillation and gastroesophageal reflux disease: Natural and therapeutic linkage of the two common diseases[J]. J Arrhythm, 2018, 35(1):43-51.
24
Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury[J]. Gastroenterology, 2009, 137(5):1776-1784.
25
Hu YF, Chen YJ, Lin YJ, et al. Inflammation and the pathogenesis of atrial fibrillation[J]. Nat Rev Cardiol, 2015, 12(4):230-243.
26
Jiang Y, Damiris K, Suero-Abreu G, et al. Reflux esophagitis is associated with higher risks of acute stroke and transient ischemic attacks in patients hospitalized with atrial fibrillation: a nationwide inpatient sample analysis[J]. Medicine (Baltimore), 2021, 100(25):e26502.
27
Rhee TM, Lee JH, Choi EK, et al. Increased risk of atrial fibrillation and thromboembolism in patients with severe psoriasis: a Nationwide Population-based Study[J]. Sci Rep, 2017, 7(1):9973.
28
Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress[J]. Curr Biol 2014, 24(10):R453-R462.
29
Feagins LA, Zhang HY, Zhang X, et al. Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines[J]. Am J Physiol Gastrointest Liver Physiol, 2008, 294(2):G411-G417.
30
Huo X, Agoston AT, Dunbar KB, et al. Hypoxia-inducible factor-2alpha plays a role in mediating oesophagitis in GORD[J]. Gut 2017, 66(9):1542-1554.
31
Li X, Yang X, Li Y, et al. Mitochondria and the pathophysiological mechanism of atrial fibrillation[J]. Curr Pharm Des, 2018, 24(26):3055-3061.
32
Bulló M, Papandreou C, García-Gavilán J et al. Tricarboxylic acid cycle related-metabolites and risk of atrial fibrillation and heart failure[J]. Metabolism, 2021, 125:154915.
33
Ren X, Wang X, Yuan M, et al. Mechanisms and treatments of oxidative stress in atrial fibrillation[J]. Curr Pharm Des, 2018, 24(26):3062-3071.
[1] 邢益民, 张天飞, 戴慧勇. 胃肠充盈超声造影检查在反酸、嗳气患者临床诊断中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 303-306.
[2] 李海云, 赵敏娴, 申英末, 杨慧琪. 胃底折叠术预防食管裂孔疝术后并发症的研究进展[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 485-490.
[3] 玉素江·图荪托合提, 韩琦, 麦麦提艾力·麦麦提明, 黄旭东, 王浩, 克力木·阿不都热依木, 艾克拜尔·艾力. 腹腔镜袖状胃切除或联合食管裂孔疝修补术对肥胖症合并胃食管反流病的中期疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 501-506.
[4] 任传富, 杨志, 徐恩, 何梓芸, 罗板鑫, 陈新, 夏雪峰. 腹腔镜疝修补术联合胃底折叠术治疗食管裂孔疝合并胃食管反流病40 例临床分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 507-511.
[5] 胡志伟, 吴继敏, 邓昌荣, 战秀岚, 纪涛, 王峰, 田书瑞, 陈冬, 张玉, 刘健男, 宋庆. 抗反流黏膜套扎治疗顽固性胃食管反流病[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 227-233.
[6] 唐小久, 胡曼, 许必君, 肖亚. 肥胖合并胃食管反流病患者严重程度与其焦虑抑郁及营养状态的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 360-364.
[7] 张静, 白亦冰, 来要良, 刘永, 和媛媛, 苏敏. 不同体位对胃食管反流病患者食管高分辨率测压的影响[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 115-120.
[8] 张靖, 柏君, 陈玉盟, 张鹏, 侯芳芳, 王军芳, 孙静, 赵士博, 杨喆, 张玥, 张瑞芳, 朱宏斌. 抗反流黏膜消融术治疗胃食管反流病患者的临床疗效[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 121-125.
[9] 华丽, 仲卫冬, 胡根, 张丽英, 邵国益. 手术治疗胃食管反流病对患者生活质量和心理状态影响的研究[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 126-129.
[10] 文明, 张丽, 谢芳, 艾克拜尔·艾力, 克力木·阿不都热依木. 构建胃食管反流病患者发生心房颤动的临床预测模型[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 130-136.
[11] 高训锋, 许晓露, 张金辉, 蔡理全, 张恒, 邰沁文. 胃食管反流病与肝胆胰系统疾病的因果关系:一项孟德尔随机化研究[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 143-152.
[12] 刘虎, 任振, 韦笑韩, 潘晨, 吴立胜. 胃食管反流伴食管运动障碍的诊疗进展[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 153-158.
[13] 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国医师协会外科医师分会胃食管反流疾病诊疗外科专家工作组, 日本肥胖治疗学会, 韩国减重与代谢外科学会. 袖状胃切除术患者胃食管反流病诊治专家共识(2024版)[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 145-162.
[14] 郑屹, 刘莹, 张煜坤, 李广平, 陈康寅, 刘彤. 既往及新发心房颤动对急性心肌梗死患者远期卒中风险的影响[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 406-417.
[15] 李芳, 戴西望, 王凯, 郭廷昊, 涂江龙. 非瓣膜性心房颤动相关性卒中的治疗研究进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 393-397.
阅读次数
全文


摘要